Patient perspectives of prosthetic heart valve choice and anticoagulation in patients with rheumatic heart disease: a semi-quantitative study - Summary - MDSpire

Patient perspectives of prosthetic heart valve choice and anticoagulation in patients with rheumatic heart disease: a semi-quantitative study

  • By

  • Shownok Saha

  • Danielle Gelbart

  • Francesco Pirone

  • David J. McCormack

  • Nishith N. Patel

  • June 8, 2026

  • 0 min

Share

Objective:

To understand the factors that influence rheumatic heart disease (RHD) patients' prosthetic heart valve choice, their knowledge of anticoagulation, and subsequent experience. This is the first RHD-specific data on valve choice, including high-deprivation populations.

Key Findings:
  • 138 patients completed or partially completed the survey from a total sample of 218 patients; mean age was 49 ± 10.
  • 61% of patients had bioprosthetic valves, while 39% had mechanical valves.
  • Younger and older patients were more likely to have bioprosthetic valves, whereas middle-aged patients preferred mechanical valves.
  • 44% of bioprosthetic valve patients specified warfarin avoidance as a reason for their choice.
  • 62% of mechanical valve patients cited avoidance of reoperation as their primary reason for valve choice.
  • 47% had not seen a dentist, and 34% had not followed up with a cardiologist post-operatively (based on different sample sizes).
Interpretation:

Surgeons and cardiologists significantly influenced valve choice among RHD patients, with many patients lacking follow-up care, which is a significant concern.

Limitations:
  • The study was conducted at a single center, which may limit generalizability.
  • The sample size was relatively small compared to the total number of patients eligible, potentially impacting the findings.
Conclusion:

A uniform evidence-based education programme for health professionals may enhance decision-making around valve choice. Additionally, free dental care and robust follow-up pathways would ensure this vulnerable group of patients is not lost to follow-up.

Original Source(s)

Related Content